We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBK icon
3851
Origin Bancorp
OBK
$1.69B
$12.7K ﹤0.01%
432
-421
-49% -$12.6K
BCBP icon
3852
BCB Bancorp
BCBP
$163M
$12.7K ﹤0.01%
1,078
+181
+20% +$2.07K
DSS icon
3853
DSS Inc
DSS
$5.18M
$12.6K ﹤0.01%
1,762
-807
-31% -$3.55K
NTRB icon
3854
Nutriband
NTRB
$38.8M
$12.6K ﹤0.01%
4,210
+1,090
+35% +$3.32K
FATBB
3855
DELISTED
FAT Brands
FATBB
$12.6K ﹤0.01%
3,067
-1,139
-27% -$4.19K
USCB icon
3856
USCB Financial Holdings
USCB
$418M
$12.6K ﹤0.01%
1,232
-499
-29% -$4.91K
SPLV icon
3857
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
$12.6K ﹤0.01%
200
+131
+190% +$8.2K
OWL icon
3858
Blue Owl Capital
OWL
$19.7B
$12.5K ﹤0.01%
1,077
-9,510
-90% -$102K
ZVRA icon
3859
Zevra Therapeutics
ZVRA
$664M
$12.5K ﹤0.01%
+2,459
New +$13.3K
VVOS icon
3860
Vivos Therapeutics
VVOS
$4.24M
$12.5K ﹤0.01%
983
-345
-26% -$3.38K
SBSI icon
3861
Southside Bancshares
SBSI
$984M
$12.5K ﹤0.01%
479
-1,827
-79% -$53.2K
ACRS icon
3862
Aclaris Therapeutics
ACRS
$863M
$12.5K ﹤0.01%
1,208
-870
-42% -$7.87K
GALT icon
3863
Galectin Therapeutics
GALT
$356M
$12.5K ﹤0.01%
8,675
+2,456
+39% +$4.17K
YSG
3864
Yatsen Holding
YSG
$319M
$12.5K ﹤0.01%
2,471
+182
+8% +$936
SKYA
3865
SkyAI Inc
SKYA
$43M
$12.5K ﹤0.01%
+2
New +$13K
AFMD
3866
DELISTED
Affimed
AFMD
$12.5K ﹤0.01%
2,083
+242
+13% +$1.94K
CERS icon
3867
Cerus
CERS
$572M
$12.4K ﹤0.01%
5,061
-7,322
-59% -$17.4K
GOOD
3868
Gladstone Commercial Corp
GOOD
$641M
$12.4K ﹤0.01%
1,006
-256
-20% -$3.07K
GIC icon
3869
Global Industrial
GIC
$1.49B
$12.4K ﹤0.01%
448
-567
-56% -$14.7K
OSPN icon
3870
OneSpan
OSPN
$624M
$12.4K ﹤0.01%
838
-953
-53% -$14.9K
TWOU
3871
DELISTED
2U Inc
TWOU
$12.4K ﹤0.01%
103
-425
-80% -$56.5K
LWAY icon
3872
Lifeway Foods
LWAY
$377M
$12.4K ﹤0.01%
1,898
-711
-27% -$4.45K
RPC
3873
Ridgepost Capital
RPC
$988M
$12.4K ﹤0.01%
1,100
+685
+165% +$7.27K
CRCT icon
3874
Cricut
CRCT
$1.24B
$12.4K ﹤0.01%
1,017
-203
-17% -$2.22K
ZDGE icon
3875
Zedge
ZDGE
$38.9M
$12.4K ﹤0.01%
5,533
+1,482
+37% +$3.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.